GUDALIA FAJARDO: Open Payments
NPI 1083019012 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,221 in 25 payments from 16 companies in 2025. Trend: 2023 $780 · 2024 $2,390 · 2025 $2,221
Food & beverage: $2,221
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $369 |
| Averitas Pharma Inc. | 1 | $145 |
| Amgen Inc. | 1 | $145 |
| Axsome Therapeutics, Inc. | 2 | $135 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
Products named: XPHOZAH 30 MG, QUTENZA, TAVNEOS, Auvelity, TARPEYO, PYRUKYND, Wegovy, Adempas.
Industry payments across MI — which companies pay providers there.
